Показано 0 из 0
Дата |
---|
24.05.2024 |
23.05.2024 |
22.05.2024 |
21.05.2024 |
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.09
|
0.09
|
|
|
|
0.295
|
|
|
|
|
0.005
|
0.005
|
|
|
|
0.295
|
|
|
|
|
0.08
|
0.08
|
|
|
|
0.295
|
|
|
|
|
0.10
|
0.10
|
|
|
|
0.295
|
|
|
|
|
0.005
|
0.005
|
|
|
|
0.295
|
|
|
|
|
0.01
|
0.01
|
|
|
|
0.295
|
|
|
|
|
0.10
|
0.10
|
|
|
|
0.295
|
|
|
|
|
0.02
|
0.02
|
|
|
|
0.295
|
|
|
|
|
0.01
|
0.01
|
|
|
|
0.295
|
|
|
|
|
0.01
|
0.01
|
|
|
|
0.295
|
|
|
|
|
Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent protected pharmaceuticals in Canada, Europe, and the United States. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs.